MetaCap

Clarivate Plc (CLVT) vs GoodRx (GDRX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

GoodRx (GDRX) has outperformed Clarivate Plc (CLVT) over the past year, losing 23.5% versus a loss of 56.3%. Over five years, GDRX leads with a -92.1% price change compared with -92.7% for CLVT. GoodRx is the larger company by market cap ($1.15 billion vs $1.04 billion), about 1.1 times the size.

On valuation, Clarivate Plc trades at a lower forward P/E (2.1x vs 9.5x for GoodRx).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLVT-56.30%GDRX-23.46%
+9%-28%-64%
Oct 8, 20251 yearOct 8, 2026
CLVT-92.34%GDRX-91.71%
+22%-40%-101%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLVT versus GDRX key metrics
MetricCLVTGDRX
Share price$1.63$3.36
Market cap$1.04B$1.15B
1-day change+10.88%+3.38%
YTD return-51.20%+23.99%
1-year return-56.30%-23.46%
5-year return-92.68%-92.08%
P/E ratio (TTM)—67.20
Forward P/E2.109.47
EPS (TTM)$-0.52$0.05
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.87$4.72
52-week low$1.42$1.77
Distance from 52-week high-57.88%-28.81%
Analyst consensusholdhold
Avg. price target upside+82.21%+17.56%
Average volume4.70M1.27M
Shares outstanding639.66M107.18M
Employees12,000697
SectorTechnologyTechnology
IndustryEDP ServicesEDP Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GDRX has outperformed CLVT by 32.8 percentage points over the past year.

About Clarivate Plc

CLVT stock →

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

Technology · EDP Services · 12,000 employees

About GoodRx

GDRX stock →

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

Technology · EDP Services · 697 employees

CLVT vs GDRX FAQ

Which is bigger, Clarivate Plc or GoodRx?

GoodRx (GDRX) is larger, with a market capitalization of $1.15B compared with $1.04B for Clarivate Plc (CLVT).

Which stock has performed better over the past year, CLVT or GDRX?

GDRX returned -23.46% over the past 12 months, compared with -56.30% for CLVT (price return, excluding dividends). Past performance does not predict future results.

Are Clarivate Plc and GoodRx in the same industry?

Yes. Both are classified in the EDP Services industry within the Technology sector.

More comparisons